Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, and Cytomegalovirus and herpesvirus research.
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
Lactose drives <i>Enterococcus</i> expansion to promote graft-versus-host disease
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
Intestinal Microbiota Injury during Allo-Hct is Generalizable across Transplantation Centers and is Associated with Increased Mortality, Broad-Spectrum Antibiotics, and Decreased Calorie Intake
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
Ex Vivo T Cell–Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission